Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 13 - Drugs for disorders of the urinary system
Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
03/2003
03/12/2003CN1402733A Angiogenic proteins and uses thereof
03/12/2003CN1402729A Polycycloalkylpurines as adenosine receptor antagonists
03/12/2003CN1402724A Thiazolidinedione derivs. as antidiabetic agents
03/12/2003CN1402721A Benzoimidazole derivs. useful as antiproliferative agents
03/12/2003CN1401385A Summer heat relieving and lithagogue beverage and producing process thereof
03/12/2003CN1401353A Chinese medicinal herbs preparation 'Shuzetong' for treating hydrops
03/11/2003US6531612 Nitrile derivatives that inhibit cathepsin K
03/11/2003US6531598 Naphthostyrils
03/11/2003US6531492 Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents
03/11/2003US6531479 Anti-cancer compounds
03/11/2003US6531471 Morpholinone and morpholine derivatives and uses thereof
03/11/2003US6531129 Heparanase specific molecular probes and their use in research and medical applications
03/10/2003CA2401358A1 Diacid-substituted heteroaryl derivatives as matrix metalloproteinase inhibitors
03/07/2003WO2002020472A1 Substituted phenylcyclohexane carboxylic acid amides and the use thereof
03/07/2003CA2421781A1 Substituted phenylcyclohexane carboxylic acid amides and the use thereof
03/06/2003WO2003018836A2 Model of autoimmune disease and methods for identifying agents against autoimmune disease
03/06/2003WO2003018758A2 Reagents and methods for smooth muscle therapies
03/06/2003WO2003018756A2 Methods for preparing purified prostaglandin e synthase
03/06/2003WO2003018611A2 Proaerolysin containing protease activation sequences and methods of use for treatment of prostate cancer
03/06/2003WO2003018579A1 Alkyne-aryl phosphodiesterase-4 inhibitors
03/06/2003WO2003018576A1 New piperidinyl-morpholinyl derivatives as modulators of chemokine receptor activity
03/06/2003WO2003018574A1 Rapamycin dialdehydes
03/06/2003WO2003018556A1 Piperidine derivatives useful as modulators of chemokine receptor activity
03/06/2003WO2003018545A1 24-sulfur-substituted analogs of 1α,25-dihydroxy vitamin d¿3?
03/06/2003WO2003018061A1 Drugs containing chymase inhibitor and ace inhibitor as the active ingredients
03/06/2003WO2003018044A1 New drug
03/06/2003WO2003018020A1 Jnk inhibitors
03/06/2003WO2003017997A1 The use of anthroquinones in the treatment of kidney disease
03/06/2003WO2003017983A1 A new extended release oral dosage form
03/06/2003WO2003017982A1 A new extended release oral dosage form
03/06/2003WO2003017946A2 Non-oxidatively metabolized compounds and compositions, synthetic pathways therefor, and uses thereof
03/06/2003WO2003017919A2 Composition comprising wenguanguo extracts, methods for preparing same and uses therof
03/06/2003WO2003017757A1 Rat with the onset of hereditary renal cancer and causative gene thereof
03/06/2003WO2002094770A3 Aminoalcohol derivatives
03/06/2003WO2002086069A3 Secreted proteins
03/06/2003WO2002083066A3 Amino acid complexes of c-aryl glucosides for treatment of diabetes and method
03/06/2003WO2002074249A3 Pharmaceuticals and methods for treating hypoxia and screening methods therefor
03/06/2003WO2002066516A3 Antibodies that bind both bcma and taci
03/06/2003WO2002064210A3 Combination therapy comprising anti-diabetic and anticonvulsant agents
03/06/2003WO2002060929A3 Polymer conjugates of neublastin and methods of using same
03/06/2003WO2002059302A3 Regulation of human serotonin-like g protein-coupled receptor
03/06/2003WO2002041837A3 Treatment of mucositis
03/06/2003WO2002034726A9 Pyrimidine-2,4,6-trione metalloproteinase inhibitors
03/06/2003WO2002024672A3 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases
03/06/2003WO2002020516A1 Novel crystals of 1,3,4-oxadiazole derivative, process for producing the crystals and medicines containing the same as the active ingredient
03/06/2003WO2001092304A3 Transporters and ion channels
03/06/2003WO2001077146A3 Compounds and methods for modulating endothelial cell adhesion
03/06/2003US20030045586 Use of amines
03/06/2003US20030045583 Novel succinate salt of O-desmethyl-venlafaxine
03/06/2003US20030045565 1-(pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives
03/06/2003US20030045554 Such as 1-(2-thien-2'-yl- 2-oxoethyl)-3-((3-phenylmethyl) pyrazol-5-yl)pyridinium bromide for treating diseases caused by the accumulation of AGE (Advanced Glycation Endproducts); antidiabetic/ antiaging agents
03/06/2003US20030045529 Method for specifically potentiating N-type Ca2+ channel activity
03/06/2003US20030045525 Particularly in the treatment of benign prostatic hyperplasia.
03/06/2003US20030045517 Nonpeptide substituted spirobenzoazepines as vasopressin antagonists
03/06/2003US20030045490 Therapeutic antisense phosphodiesterase inhibitors
03/06/2003US20030044898 Nucleotide sequences coding polypeptide for use in the treatment of asthma, parkinson's, heart defects, hypotension, urogenital and bone disorders
03/06/2003US20030044893 Nectin polypeptides, polynucleotides, methods of making and use thereof
03/06/2003US20030044464 Sustained-release, oral pharamaceutical forms of formulation
03/06/2003US20030044386 Genetic engineering; nucleic acid coding cytokines
03/06/2003US20030041602 Process for production of nanoparticles and microparticles by spray freezing into liquid
03/06/2003CA2458574A1 Reagents and methods for smooth muscle therapies
03/06/2003CA2458565A1 New angiogenesis inhibitors based on soluble cd44 receptor hyaluronic acid binding domain
03/06/2003CA2458131A1 Jnk activation inhibitor
03/06/2003CA2458129A1 The use of anthroquinones in the treatment of kidney disease
03/06/2003CA2457903A1 Proaerolysin containing protease activation sequences and methods of use for treatment of prostate cancer
03/06/2003CA2457532A1 Non-oxidatively metabolized compounds and compositions, synthetic pathways therefor, and uses thereof
03/06/2003CA2457341A1 A new extended release oral dosage form
03/06/2003CA2457339A1 A new extended release oral dosage form
03/06/2003CA2455311A1 Rapamycin dialdehydes
03/06/2003CA2451740A1 Composition comprising wenguanguo extracts, methods for preparing same and uses thereof
03/06/2003CA2442761A1 Drugs comprising chymase inhibitors and ace inhibitors as effective ingredients
03/06/2003CA2421499A1 Novel crystals of 1,3,4-oxadiazole derivative, process for producing the same and pharmaceutical agent containing the same as active ingredient
03/05/2003WO2002020566A2 NOVEL MMP-2 DERIVATIVES FOR USE AS INHIBITORS OF INTEGRIN αVβ¿3?
03/05/2003EP1288299A2 TRNA synthetase
03/05/2003EP1288298A2 TRNA synthetase from Staphylococcus aureus
03/05/2003EP1288206A1 Substituted benzenesulfonamide derivatives as prodrugs of COX-2 inhibitors
03/05/2003EP1287035A1 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
03/05/2003EP1287020A2 Cancer diagnosis and assays for screening anti-cancer agents
03/05/2003EP1287001A1 Thiophene derivatives useful as anticancer agents
03/05/2003EP1286989A2 Prodrug of an ice inhibitor
03/05/2003EP1286986A1 Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain
03/05/2003EP1286975A1 Biclyclic cyclohexylamines and their use as nmda receptor antagonists
03/05/2003EP1286973A2 Novel carbamates and carbamides, production and use thereof as endothelin receptor antagonists
03/05/2003EP1286972A1 Pyrimidine compounds
03/05/2003EP1286962A1 2-ethyl and 2-ethylidene-19-nor-vitamin d compounds
03/05/2003EP1286673A2 Ligands of integrin receptors
03/05/2003EP1286591A1 Treating smooth muscle hyperactivity with (r)-oxybutynin and (r)- desethyloxybutynin
03/05/2003EP1140923B1 Method for preparing (r)- (+) -3 1- 2-( 4-benzoyl- 2-(3,4- difluorophenyl)morpholin- 2-yl)ethyl]- 4-phenylpiperidin -4-yl -1,1- dimethylurea, its salts solvates and/or hydrates
03/05/2003EP1084569B1 Androgens in combination with gestagens for compensating for a testosterone deficiency in men while simultaneously protecting the prostate
03/05/2003EP0892791B1 N-[[4-(5-METHYL-3-PHENYLISOXAZOL-4-YL]PHENYL]SULFONYLPROPYLAMIDE and its SODIUMSALT AS PRODRUGS OF COX-2 INHIBITORS
03/05/2003EP0801067B1 Novel quinuclidine derivatives and medicinal composition thereof
03/05/2003EP0667784B1 Inhibitors of cell regulatory factors and methods for preventing or reducing scarring
03/05/2003CN1400974A Amino acid derivatives and use thereof as NEP, ACE and ECE inhibitors
03/05/2003CN1400968A Method for preparing alpha sulfonyl hydroxamic acid derivatives
03/05/2003CN1400898A 回旋酶抑制剂及其用途 Gyrase inhibitors and their use
03/05/2003CN1400005A Chinese medicine for boosting brain and supplementing kidney and its preparation method
03/05/2003CN1399960A Medicine for promoting recovery of renal function
03/05/2003CN1102596C 5H-thiazole [3,2-a] pyrmidine derivatives
03/05/2003CA2421283A1 Novel mmp-2 derivatives for use as inhibitors of integrin .alpha.v.beta.3
03/04/2003US6528681 Halogenated triphenylethylene derivatives as selective estrogen receptor modulators
1 ... 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 ... 562